Global real estate investor Ivanhoé Cambridge and developer Lendlease have launched a life science joint venture that will deliver labs, offices and manufacturing spaces in high-growth life science clusters across the US.
Investment in US life sciences real estate is poised to grow another 10% minimum this year, according to recent research from CBRE's capital markets team.
That's on top of a whopping 62% increase last year. Investment in life sciences real estate reached $21.4 billion in 2021, CBRE says, and investment in the sector has grown by 111% since 2018.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
